MedTrace Logo

Predictors of Future Type 2 Diabetes Mellitus in Circassians Minority in Israel

NCT01311401 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 670

Last updated 2013-02-20

No results posted yet for this study

Summary

The aim

The aim of the present study is:

1. The metabolic risk factors that can predict diabetes after 10 years in a Circassians population-based sample of people who were aged 35 years or older and living in Israel.
2. To define the incidence of type 2 diabetes mellitus in Circassians minority in Israel.

The hypothesis of the study:

High fasting glucose has the most powerful predictive value for type 2 diabetes mellitus in the future.

The claimed importance of the study:

Finding a powerful risk factor for future diabetes mellitus can contribute to intensifying the preventive measures in a small part of the population, by that to reduce the incidence of new diabetes without increasing the health cost.

Conditions

  • Diabetes Mellitus Type II

Interventions

OTHER

NONE intervention

NONE intervention

Sponsors & Collaborators

  • Clalit Health Services

    collaborator OTHER

  • Ziv Hospital

    lead OTHER_GOV

Eligibility

Min Age
35 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2009-10-31
Primary Completion
2014-07-31

Countries

  • Israel

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01311401 on ClinicalTrials.gov